Clinical trials
Completed Non-Muscle Invasive Bladder Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Rome Tor Vergata | 2 |
| UroGen Pharma Ltd. | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| Cepheid | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| Paolo Puppo | 1 |
| Savino M. Di Stasi | 1 |
| University of Trieste | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 11 |
| Urinary Bladder Neoplasms | 6 |
| Lower Urinary Tract Symptoms | 1 |
| Recurrence | 1 |
| Urinary Bladder Diseases | 1 |
| Urologic Diseases | 1 |
| Urologic Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.